LCMS Bioanalysis of Antibody Drugs Using Fabselective Proteolysis "nSMOL Method" - Part 6 - Improvement of Reaction Conditions for Automated Analyses -
Aplikace | 2018 | ShimadzuInstrumentace
LC/MS, LC/MS/MS, LC/QQQ
ZaměřeníKlinická analýza
VýrobceShimadzu
Klíčová slovashaking, nsmol, static, condition, constant, reaction, trastuzumab, antibody, proteolysis, bevacizumab, guideline, nivolumab, nsmoltm, validation, accuracy, rituximab, criteria, without, enzymatic, peak, area, asgitfsnsgmhwvr, drug, respect, asgytftsynmhwvk, method, set, ftfsldtsk, technology, flow, news, iyptngytr, selective, cdr, chief, kit, fixing, shimadzu, fulfilled, pharmacokinetics, fab, average, enables, shaker, precision, satisfy, observations, under, confirms, issued
Podobná PDF
LCMS Bioanalysis of Antibody Drugs Using Fab- selective Proteolysis "nSMOL Method" - Part 6
2018|Shimadzu|Aplikace
LAAN-A-LM-E141 Application News No. C174 nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fabselective Proteolysis "nSMOL Method" - Part 6 - Improvement of Reaction Conditions for Automated Analyses - nSMOLTM Antibody BA Kit Features nSMOL is a…
Klíčová slova
shaking, shakingnsmol, nsmolstatic, staticcondition, conditionconstant, constantreaction, reactiontrastuzumab, trastuzumabantibody, antibodyproteolysis, proteolysisbevacizumab, bevacizumabguideline, guidelinenivolumab, nivolumabnsmoltm, nsmoltmvalidation, validationaccuracy
Shimadzu Solutions for Biopharmaceutical - Application Notebook
2018|Shimadzu|Příručky
C10G-E054 Solutions for Biopharmaceutical Application Notebook First Edition: December, 2017 © Shimadzu Corporation, 2017 Solutions for Biopharmaceutical Index Application Notebook Bioanalysis LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Trastuzumab analysis nSMOL, which enables selective proteolysis of the…
Klíčová slova
acid, acidamino, aminoantibody, antibodyglycan, glycannsmol, nsmolerexim, ereximstructure, structurenews, newsaggregates, aggregatesanalysis, analysisnucleic, nucleicmrm, mrmglycans, glycanssizer, sizeraggregate
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis -
2017|Shimadzu|Aplikace
LAAN-A-LM-E118A Application News No. C147A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that…
Klíčová slova
nivolumab, nivolumabnsmol, nsmolantibody, antibodystructure, structureaccuracy, accuracynsmoltm, nsmoltmpeptides, peptidesimmunological, immunologicalconfirmation, confirmationdrugs, drugsvalidation, validationaverage, averageimmune, immunequantitation, quantitationbioanalysis
LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis -
2017|Shimadzu|Aplikace
LAAN-A-LM-E118A Application News No. C147A nSMOLTM Antibody BA Kit LCMS Bioanalysis of Antibody Drugs Using Fab-Selective Proteolysis nSMOL - Part 3 - Nivolumab analysis - nSMOLTM Antibody BA Kit Features nSMOL is Shimadzu's completely new and breakthrough technology that…
Klíčová slova
nivolumab, nivolumabnsmol, nsmolantibody, antibodystructure, structureaccuracy, accuracynsmoltm, nsmoltmpeptides, peptidesimmunological, immunologicalconfirmation, confirmationdrugs, drugsvalidation, validationaverage, averageimmune, immunequantitation, quantitationbioanalysis
